SAN MATEO, Calif.--(BUSINESS WIRE)--Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its third quarter financial results for 2009.
SAN MATEO, Calif.--(BUSINESS WIRE)--Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its third quarter financial results for 2009.
